Glonghui July 27th 丨Meikang Biology (300439.SZ)Announced that Ningbo Meikang Shengde, a wholly-owned subsidiary of the companybiotechnologyThe company recently obtained the “People's Republic of China Medical Device Registration Certificate” issued by the Zhejiang Drug Administration. The product name is a fully automatic glycated hemoglobin analyzer. The scope of application is for quantitative testing of glycated hemoglobin in blood.

The acquisition of the “Registration Certificate” for the liquid chromatography analysis instrument mentioned above by Ningbo Meikang Shengde Biotechnology Co., Ltd. has further enriched and improved the variety of the company's product line, better met the diversification needs of the market, is conducive to improving the company's core competitiveness and market expansion capabilities, and will have a positive impact on the company's future operations. The actual sales situation of the above products depends on future marketing effects. The company is currently unable to predict its impact on the company's future performance. Investors are kindly requested to pay attention to investment risks.